Walter and miller’s textbook of radiotherapy: radiation physics, therapy and oncology 8th edition ed

Page 1


https://ebookmass.com/product/walter-and-millers-

More products digital (pdf, epub, mobi) instant download maybe you interests ...

Practical Radiation Oncology Physics: A Companion to Gunderson & Tepper's Clinical Radiation Oncology, 1e Sonja Dieterich Phd

https://ebookmass.com/product/practical-radiation-oncologyphysics-a-companion-to-gunderson-teppers-clinical-radiationoncology-1e-sonja-dieterich-phd/

Fundamentals of Radiation Oncology: Physical, Biological, and Clinical

https://ebookmass.com/product/fundamentals-of-radiation-oncologyphysical-biological-and-clinical/

Clinical Radiation Oncology, 4e Fourth Edition Bogart

https://ebookmass.com/product/clinical-radiationoncology-4e-fourth-edition-bogart/

Handbook

of Palliative Radiation Therapy 1st Edition

https://ebookmass.com/product/handbook-of-palliative-radiationtherapy-1st-edition/

Hematology – Oncology Therapy 2nd Edition

https://ebookmass.com/product/hematology-oncology-therapy-2ndedition/

Imaging for Clinical Oncology [Radiotherapy in Practice] 2nd Edition Peter Hoskin

https://ebookmass.com/product/imaging-for-clinical-oncologyradiotherapy-in-practice-2nd-edition-peter-hoskin/

Principles and Practice of Radiation Therapy E Book 4th Edition, (Ebook PDF)

https://ebookmass.com/product/principles-and-practice-ofradiation-therapy-e-book-4th-edition-ebook-pdf/

Gunderson & Tepper’s Clinical Radiation Oncology 5th Edition Joel Tepper

https://ebookmass.com/product/gunderson-teppers-clinicalradiation-oncology-5th-edition-joel-tepper/

Gunderson & Tepper’s Clinical Radiation Oncology 5th Edition Edition Joel Tepper

https://ebookmass.com/product/gunderson-teppers-clinicalradiation-oncology-5th-edition-edition-joel-tepper/

WalterandMiller’s TEXTBOOK OF RADIOTHERAPY

RadiationPhysics,TherapyandOncology

EIGHTHEDITION

PaulSymonds TDMDFRCPFRCR

EmeritusProfessorofClinicalOncology,UniversityofLeicester,Leicester,UK;Honorary ConsultantOncologist,UniversityHospitalsofLeicester,Leicester,UK

JohnA.Mills PhDMIPEMCPhys

Physicist,MACS-QualityControlProvider,JamesWattHouse,Hinckley,UK

AngelaDuxbury FCRTDCRMSc

EmeritusProfessorofTherapeuticRadiography,SheffieldHallamUniversity,Sheffield,UK

©2019,ElsevierLimited.Allrightsreserved.

Firstedition1950

Secondedition1959

Thirdedition1979

Fourthedition1979

Fifthedition1993

Sixthedition2003

Seventhedition2012

Nopartofthispublicationmaybereproducedortransmittedinanyformorbyanymeans,electronicor mechanical,includingphotocopying,recording,oranyinformationstorageandretrievalsystem,without permissioninwritingfromthepublisher.Detailsonhowtoseekpermission,furtherinformationaboutthe Publisher’spermissionspoliciesandourarrangementswithorganizationssuchastheCopyrightClearance CenterandtheCopyrightLicensingAgency,canbefoundatourwebsite: www.elsevier.com/permissions

ThisbookandtheindividualcontributionscontainedinitareprotectedundercopyrightbythePublisher(other thanasmaybenotedherein).

Notices

Practitionersandresearchersmustalwaysrelyontheirownexperienceandknowledgeinevaluatingand usinganyinformation,methods,compoundsorexperimentsdescribedherein.Becauseofrapidadvances inthemedicalsciences,inparticular,independentverificationofdiagnosesanddrugdosagesshouldbe made.Tothefullestextentofthelaw,noresponsibilityisassumedbyElsevier,authors,editorsorcontributors foranyinjuryand/ordamagetopersonsorpropertyasamatterofproductsliability,negligenceorotherwise, orfromanyuseoroperationofanymethods,products,instructions,orideascontainedinthematerialherein.

ISBN:978-0-7020-7485-1

ContentStrategist:PoppyGarrawaySmith/SerenaCastelnovo ContentDevelopmentSpecialist:VeronikaWatkins

ProjectManager:ManchuMohan Design:BridgetHoette

IllustrationManager:NarayananRamakrishnan

PrintedinChina

Lastdigitistheprintnumber:987654321

Contributors,xix

InternationalSystemofUnitsandPrefixesforPhysical Quantities,xxiii

SECTION1

1 Atoms,NucleiandRadioactivity, 2 ElizabethM.Parvin Introduction,2 AtomicStructure,2 Particles,2 TheAtomandtheNucleus,3 TheForces,3 ElectronEnergyLevels,4 BandTheoryofSolids,4 ImpurityBands,5 ParticlesinElectricandMagneticFields,5 ElectricFields,5 MagneticFields,5 TheLorentzEquation,5 Waves,5 TransverseandLongitudinalWaves,5 ElectromagneticRadiation,6 ContinuousSpectraandCharacteristicRadiation,7 RadioactiveDecay,8 StableandUnstableIsotopes,8 Half-life,9 AlphaDecay,9 BetaDecay,10 GammaDecay,10 ElectronCaptureandInternalConversion,11 RadioactiveDecaySeries,11 RadionuclidesofMedicalInterest,12 References,12 FurtherReading,12

2 InteractionsofIonisingRadiationWithMatter, 13 ShakardokhtJafariandMichaelWynne-Jones Introduction,13 ChargedandUnchargedParticles,13 ExcitationandIonisation,13 ElectronInteractions,14 CollisionalandRadiativeEnergyLoss,14 X-RayProduction,14 CharacteristicX-RaysandAugerElectrons,16 StoppingPowerandLinearEnergyTransfer,16 RangeandPathLength,17 PhotonInteractions,17 ThePhotoelectricEffect,17 TheComptonEffect,18 PairProduction,19 ExponentialAttenuation,19 AttenuationofPhotonSpectra,21

BeamHardening,21 EnergyAbsorption,22 Photo-NuclearInteractions,22 PhotonDepthDoseandtheBuild-UpEffect,22 KermaandAbsorbedDoseforRadiotherapy beams,24 Kerma,24 AbsorbedDose,24 UnitsofKermaandDose,25 HeavyChargedParticleInteractions,25 Protons,25 CarbonIonsandPions,25 NeutronInteractions,26 References,27 FurtherReading,27

3 RadiationDetectionandMeasurement, 28 AndrewPoynter,AndrzejKacperek,andJohnA.Mills Introduction,28 RadiationDetection,28 GasAmplificationDevices,29 ScintillationDevices,30 IdealAirIonisationChamber,30 ProtonBeamDetection,30 MeasurementandStandardisationofDose,31 DoseStandards,31 TraceabilityofMeasurement,31 StandardCalorimeter,32 TheFreeAirChamber,33 TheProtonBeamDoseStandard,34 PracticalIonisationChambers,34 Bragg–GrayCavityTheory,34 DoseDeterminationBasedonCalibrated Instruments,35 RequirementsforPracticalIonisationChambers,35 ThimbleIonisationChamber,35 PhysicalDescription,35 MeasurementofDoseandDoseRate,36 TheParallel-PlateIonisationChamber,37 TheBeamMonitorChamber,37 IntercomparisonsWithSecondaryStandard Instruments,38 StrontiumConsistencyCheckDevice,38 IonisationChamberCorrections,38 IonRecombinationLosses,38 CorrectionforAtmosphericConditions,38 ChamberStemEffect,39 PolarityEffect,39 AlternativeDoseMeasurementSystems,39 FilmDosimetry,39 SemiconductorDetectors,40 ThermoluminescentDosimetry,42 ChemicalandBiochemicalDetectors,43 FrickeDosimetry,43

CericDosimetry,44

GelDosimetry,44 FrickeGelsandFXGGels,44 PolymerGels,44

Alanine-ElectronParamagneticResonance Dosimetry,44

BiologicalDosimetry,45

BiologicalMolecules,45

GeneticStructures,45

CellsandBiologicalStructures,45 CompositeDetectorsandArrays,45 LinearDetectorArrays,45 AreaArrays,45 VolumeDetectorsArrays,46

ElectronicPortalDosimetry,46 AlternativeSystemsforProtonBeamsDose Measurement,46 References,47

4 RadiationProtection, 49 MikeDunn Introduction,49 BiologicalEffectsofRadiation,49 StochasticHereditaryEffects,49 StochasticSomaticEffects,50 NonstochasticSomaticEffects,50 DoseDescriptors,50 EquivalentDose,50 EffectiveDose,50 BackgroundRadiation,52 LegislativeRequirements,53

TheIonisingRadiationsRegulations2017,53

TheIonisingRadiation(MedicalExposure) Regulations2017,56 AdministrationofRadioactiveSubstancesAdvisory Committee,57 EnvironmentalPermitting(EnglandandWales) Regulations2016,58 HighActivitySealedRadioactiveSourcesandOrphan SourcesRegulations2005,58 ProtectiveMeasures,58 Time,58 Distance,58 Barriers,58 Contamination,59 BuildingMaterials,59 MonitoringofRadiationLevels,60 PersonalRadiationDosimeters,60 RadiationRecords,61 OtherRequirements,61 References,62

5 ImagingWithX-Ray,MagneticResonanceImagingand Ultrasound, 64 AndyRogers,CarlTiivas,andSarahWayte Introduction,64 X-RayImaging,65 OverviewofX-RayImagingProcess,65

ProductionofX-RaysforImaging,65 InformationFromAbsorptionandScattering,66 DifferentialAttenuationinthePrimaryBeam,66 ContrastMedia,66 ScatterasUnwantedBackground,66 AntiscatterGrid,66 PlanarImaging,67 FilmandScreenDetection,67 CharacteristicCurve,68

DigitalComputedRadiographyUsing PhotostimulablePhosphors,68 FluoroscopicImagingWithImageIntensifier Chain,68

DigitalFluoroscopyandRadiographyUsingSolid StateDetectors,69 AssessmentofImageQuality,69 MagnificationDistortion,69 Resolution,GeometricUnsharpnessandMovement,69 ImageSignalandNoise,70 Dose,70 TomographicImaging,70 ComputedTomographicReconstructionFrom Projections,70 PracticalConfigurations,70 DedicatedRadiotherapySystems,71 Simulator,71 ComputedTomographyVirtualSimulator,71 TreatmentVerificationSystems,71 MagneticResonanceImaging,72 OverviewoftheMagneticResonanceImaging Process,72 ProducingaSignal,72 ReturningtoThermalEquilibrium,72 ImagingSequences,73 HowContrastIsAlteredinaMagneticResonance Image,73 HowPositionalInformationIsEncodedinthe Signal,73 MagneticResonanceImagingScanners,75 Spectroscopy,76 ClinicalApplicationsofMagneticResonanceImaging inoncology,77 BrainTumours,77 BodyTumours,77 UltrasoundImaging,77 OverviewofUltrasoundImagingProcess,77 PhysicalCharacteristicsofUltrasoundWaves,77 InteractionsatInterfaces,81 AttenuationandInterference,81 UltrasoundScanners,81 ProductionofUltrasoundforImaging,81 DerivationofanUltrasoundImage,82 BrightnessModeUltrasoundImaging,82 LinearArrayUltrasoundImaging,82 IntracavitaryandEndoscopicProbes,82 HarmonicImaging,82 DynamicImaging,82

ContrastandTissueCharacteristicImaging,83 ClinicalApplicationsofUltrasoundImaging,83 GeneralImaging,83

AdvantagesandDisadvantages,83 ImagingforCancer,84 ClinicalTherapeuticUltrasound,84 References,84

6 ImagingWithRadionuclides, 85 PaulHinton Introduction,85 OverviewoftheRadionuclideImagingProcess,85 GammaCameras,86

ScintillationGammaCameras,86 Solid-StateGammaCameras,87 ImageConstruction,87 ImagingTechniques,88 PositronEmissionTomographyScanners,90 Radiopharmaceuticals,92

TheRadionuclide,92 TypeofRadiation,92 PhysicalHalf-Life,92 SpecificActivity,92 RadionuclidePurity,92 ChemicalProperties,92

TheIdealRadionuclideforImaging,92 MechanismsofLocalisation,92 ProductionandQualityControlof Radiopharmaceuticals,93 ClinicalApplications,94

BoneImaging,94

TumourImaging,94 ImagingThyroidCancer,96

CardiacImaging,96 KidneyImaging,97 InfectionImaging,98

SentinelNodeMapping,99

PositronEmissionTomographicImaging,99 Conclusions,101 References,101

7 TherapyWithUnsealedRadionuclides, 102 MatthewAldridgeandSofiaMichopoulou Introduction,102

Iodine-131intheTreatmentofThyroidDisease,103 ThyroidCancer,103

BenignThyroidDisease,105 PalliationofBonePain,105

MolecularRadiotherapyTreatmentofNeuroendocrine Tumours,106

SelectiveInternalRadiationTherapy,106

Phosphorus-32intheTreatmentofRefractory MyeloproliferativeDisease,107

IntraarticularandIntracavitaryTreatments,107 Radioimmunotherapy,107

RadiationProtection,WasteandRegulations,108 HospitalRequirements,108 Facilities,108

ComfortersandCarers,108 OutpatientTherapies,108 WasteDisposal,108 References,109

8 RadiotherapyDevicesWithKilovoltageX-Raysand Radioisotopes, 110 ClaireFletcherandJohnA.Mills Introduction,110 KilovoltageX-RayProduction,110 X-RaysFromElectrons,110 High-VoltageCircuits,110 KilovoltageX-RayCharacteristics,111 SuperficialandDeepKilovoltageMachines,111 TubeStand,112 Collimation,112 SkinandEyeShielding,112 ControlofOutput,113 CalibrationofDoseOutput,113 ContactKilovoltageMachine,113 GrenzKilovoltageMachine,113 RadionuclideCharacteristics,114 GammaEmitters,114 BetaEmitters,114 BrachytherapyandAfterloadingMachines,114 TheHighDoseRateAfterloadingMachine,116 ImplantedKilovoltageMachine,116 Beta-RayMachine,117 Gamma-RayMachine,117 RadioisotopeSource,118 BeamCollimation,118 DesignofGamma-RayTeletherapyMachines,119 Radiosurgery,120 RadiationSafety,120 CommissioningandQualityControl,120 Conclusion,120 References,121

9 BeamProduction:MegavoltageAccelerators, 122 AndrzejKacperekandJohnA.Mills Introduction,122 TheMedicalLinearAccelerator,122 LinearAcceleratorLayoutandComponents,123 X-RayBeam,124 ElectronBeam,126 LinearAcceleratorControlSystems,127 NonstandardLinearAccelerators,127 Intensity-ModulatedRadiotherapy,127 CyberKnife,127 Tomotherapy,127 Volumetric-ModulatedArcTherapy,127 StereotacticAblativeRadiotherapy,127 FlatteningFilter-FreeDoseDelivery,128 PatientAlignmentforX-RayandElectronTherapy,128 RadiationSafety,131 Acceptance,CommissioningandQualityControl,131 TreatmentRoomDesignforX-RayandElectron Protection,131

SpecialTechniquesWithLinearAccelerators,132

TheDevelopmentofClinicalProtonandHeavier ChargedParticleAccelerators,133

ParticleAcceleratorLayoutandComponents,134

BasicComponentsofaCyclotron,134

BasicTheoryofClassicCyclotron Operation,134

IonSourceOperation,135

CharacteristicsandLimitationsforTherapy,136

Synchrocyclotrons,136

AzimuthalVerticalFocussingorIsochronous Cyclotrons,136

Synchrotrons,137

Passive-ScatteredBeamsandPencilBeamScanning Beams,138

Gantries,142

TypesofProtonandIonAccelerators,143

ClinicalProtonTherapyCentres,143

ClinicalCarbonIonTherapyCentres,145 NoncircularAccelerators,145

NeutronandOtherBeams,146

FastNeutronBeamTherapy,146

BoronNeutronCaptureTherapy,146

ProtonBoronCaptureTherapy,146

PionTherapy,147

AntiprotonTherapyBeams,147

Laser-InducedProtonandParticle Beams,147

ShieldingofProtonTherapyAcceleratorsand TreatmentRooms,148

Nanoparticle-EnhancedTherapy,148

FutureDesign,149

RecordandVerifySystems,149 Conclusion,150 References,150

10 RadiationTreatmentPlanning:Immobilisation, LocalisationandVerificationTechniques, 152

AndrewPennyandPhilSharpe Introduction,152

PatientImmobilisation,153

ThermoplasticShells,153

PatientHeadShells,154

ThreeDimensionalPrinting,154

NonshellFixationSystems,154

StereotacticFrames,154

BodyImmobilisation,155

StereotacticAblativeBodyRadiationTherapy,155 Surface-GuidedRadiotherapy,155 VolumeDefinitions,155

NoncomputedTomographyContouring Devices,156 PhysicalSimulation,156 ComputedTomographySimulation,157 VirtualSimulation,157

ATypicalHeadandNeckComputedTomography SimulationProcedure,159 MultimodalityImagesforPlanning,159

PortalVerificationandImage-Guided Treatments,160 PortalImaging,160 Image-GuidedRadiotherapy,160 References,161

11 RadiationTreatmentPlanning:BeamModels,Principles andPractice, 162

MariaManiaAspradakis Introduction,162 RepresentationofthePatientforTreatment Planning,163 ThePlanningCT,163 PatientImmobilisationforTreatment Planning,164 MotionManagementinTreatment Planning,164

MagneticResonance–BasedPlanning,164 BeamModellingandDoseCalculationsforExternal MVPhotonBeamTreatmentPlanning,164 ModellingoftheSourceofRadiation,165 ModellingofDoseintheIrradiatedMedium,166 Factor-BasedApproaches,169 ConclusiononModel-BasedApproaches,170 DosePerMonitorUnitFormalism:Calculationof MonitorUnits,170 TreatmentPlanEvaluationTools,170 IsodoseDistributions,170 BeamsEyeView,171 DoseVolumeHistograms,171 OtherTools,173 TreatmentPlanningTechniquesinExternalMV PhotonBeamRadiotherapy,174 ForwardandInversePlanning,174 ForwardPlanningWithStandardBeam Arrangements,174 Forward-PlannedIntensity-Modulated Radiotherapy,180 InversePlanning,181 SpecialisedTechniquesWithMVPhotons,183 ElectronTherapy,185 DoseCalculationsforElectronBeams,185 EnergyandDepth-DoseCharacteristics,185 Penumbra,186 StandoffandStandin,186 PatientContourEffects,186 Heterogeneities,187 FieldMatching,187 SpecialisedTechniquesWithElectrons,187 KilovoltagePhotonTherapy,188 DifferencesBetweenKilovoltageandElectron Therapy,188 ProtonandHeavy-IonTherapy,188 QualityAssuranceinTreatmentPlanning,189 TreatmentPlanningSystemCommissioningand PerformanceTesting,189 Plan-SpecificQualityAssurance,190 References,191

12

Networking,Data,ImageHandlingandComputing inRadiotherapy, 193

JohnSage Introduction,193 History,193

BenefitsandHazardsofComputerisation,193 Networking,194

LinkLayer:PhysicalInfrastructure,194

NetworkLayer:Addressing,194

TransportLayer:SendandReceive,195

ApplicationLayer:TheProgram,195 NetworkSecurity,195

DICOM,195

DICOMDataObjects,196

RadiotherapyData,197

DataStorage,197 ImageQuality,197

RadiotherapyDataTypes,197

DataBurden,198 DataSecurity,198 SoftwareDevelopment,199 Conclusion,199 References,199

13 QualityControl, 200 JohnA.MillsandPhilSharpe Introduction,200

TheQualityControlRequired,200 CommitmenttoQualityControl,201 Safety,PositionandDose,201 Frequency,TolerancesandFailureTrends,201 MeasurementandUncertainty,201 NullHypothesis,202 CombiningVariancesandTolerances,202 SettingaTolerancetoAchieveaPerformance Level,202 PerformanceImprovement,202 MaintenanceandCatastrophes,203 Long-Term,Short-TermandImmediate Monitoring,203 ImmediateMonitoring,203 Long-TermMonitoring,203 Short-TermMonitoring,203

TheRadiotherapyProcess,203 Acquisition,204 Analysis,204 Delivery,204

TheNeedforPatient-SpecificQualityControl,204 TheRadiotherapyTechnology,204 PlanningImaging,204 VirtualSimulation,204

DosePrediction,205

KilovoltageMachines,205

AfterloadingBrachytherapyMachines,205 MegavoltageMachines,205

PatientPositioning,205 TreatmentVerification,205

ComputerSystemsandNetworking,205 MeasurementEquipment,205 PracticalPatient-SpecificQualityControl,206 PracticalMethods,206 Phantom-BasedMeasurements,206 DosimetricArrays,206 GammaIndex,206 IndependentSoftwareVerification,207 SecondaryTreatmentPlanningSystem,207 Patient-SpecificQualityControlImplementation,207 GettingThingsinBalance,207 QualityControlSchedulingforMegavoltage Machines,207 Conclusion,208 References,208

14 QualityManagementinRadiotherapy, 209 JillEmmerson,KarenWaite,andHelenBaines Introduction:WhatisQuality?,209 HistoryofQualityinRadiotherapy,210 QualityManagementSystems,210 1.CustomerFocus,210 2.Leadership,211 3.EngagementofPeople,211 4.ProcessApproach,211 5.Improvement,211 6.Evidence-BasedDecisionMaking,211 7.RelationshipManagement,211 TheISO9000Standard,212 Clause4ContextoftheOrganisation,212 Clause5Leadership,213 Clause6Planning,213 Clause7Support,213 Clause8Operation,213 Clause9PerformanceEvaluation,214 Clause10Improvement,214 TheRadiotherapyProcess,214 AnIntegratedApproachtoQualityandOther Initiatives,214 QualityintheNationalHealthService,214 RiskManagement,214 ClinicalIncidents,216 Audit,217 Patient-FocussedCare,220 ImplementationofNewTechnologyandNew Techniques,221 Conclusion,222 References,222

SECTION2

15 EpidemiologyofCancerandScreening, 226 KatieSpencer,DavidHole,PaulSymonds,andEvaMorris TheCancerProblem,226 CancerintheUnitedStates,226 CancerinEurope,227

EpidemiologyofCancer,227

Terminology,227

SurvivalandCureinCancer,227

OutcomeofPalliativeCare,228

EpidemiologyandThePreventionofCancer,228

CriteriaforCausality,228

AetiologyandScreening,228

LungCancer,228

ColorectalCancer,230

Breast,230

Stomach,232

Prostate,232

Cervix,232

Oesophagus,233

Melanoma,233

HeadandNeck,233

Lymphoma,234

Leukaemia,234

ReducingtheRisksofDevelopingCancer,235

ReducingTobaccoSmoking,235

ModifyingAlcoholConsumption,236

HPVVaccination,236

UltravioletLight,236

OccupationalExposure,236

Diet,237

IonisingRadiation,237

Pollution,237

Chemoprevention,237

Conclusion,238

FurtherReading,238

16 BiologicalandPathologicalIntroduction, 239

JohnR.GoepelandAbhikMukherjee

Introduction,239

Growth:Proliferation,DifferentiationandApoptosis, 239

GrowthDisorders,239

Neoplasia,240

BenignandMalignantNeoplasms,240 Carcinogenesis,240

Initiation,240

Promotion,240

Progression,240

ClinicalCancer,241

OncogenesandTumourSuppressorGenes,241

Defectiveapoptoticmechanisms,241

BloodVessels,241

PhysicalAgents,242

Chemicals,242

VirusesandCancer,243

ImmunityandCancer,243

InjuryandCancer,243

PrecancerousLesions,243

FieldChange,244 NaturalHistoryandSpreadofCancer,244

LocalInvasion,244

Metastasis,245

FunctioningTumours,246

CauseofDeathfromCancer,246 StagingofCancers,246 TNMClassification,246 HistologicalGrading:Differentiation,247 LimitationsofGrading,248 GrowthRateofCancers,248 SpontaneousRegressionofCancer,248 ClassificationofNeoplasms,248 UndifferentiatedTumours,249

CurrentAdvancesinPathologyGuidingPatient Management,251 FurtherReading,252

17 Molecular,CellularandTissueEffectsof Radiotherapy, 253

GeorgeD.D.JonesandPaulSymonds Introduction,253 IonisingRadiation,FreeRadicalGeneration, SubcellularRadiogenicDamage,253 Recovery,DNADamageRepairandDamage Signalling,255 Recovery,255 Double-StrandBreakRepairandDamage Signalling,255 EpigeneticRadiationSignallingMechanisms,255 Radiation-InducedCellKilling,257 TumourHypoxia,OxygenEffectand Reoxygenation,257 TheCellCycleandSensitivitytoIrradiation,259 PatternsofCellDeathAfterIrradiation,259 ModelsofRadiationCellSurvival,260 RadiationEffectsinNormalandMalignant Tissue,261 AcuteResponsesofNormalTissue,261 SubacuteReactionsofNormalTissue,261 TheEffectofRadiotherapyonTissues,261 TheToleranceofNormalTissues,261 Retreatment,262 ResponseofTumourstoRadiation,262 OverallTreatmentTime,262 ModificationofFractionationPatterns,262 OtherRadiationModalities,262 HeavyParticleRadiotherapy,262 Drug–RadiotherapyCombinations,263 FutureTrends(andPitfalls),263 NewTechnologies,263 MolecularStudies,263 FurtherReading,264

18 PrinciplesofManagementofPatientsWithCancer, 265 PaulSymondsandAngelaDuxbury Introduction,265 FactorsGoverningClinicalDecisions,266 TumourFactors,266 PatientFactors,267 TreatmentModality,267 SupportServices,269 PalliativeCare,270

PainControl,270

NauseaandVomiting,271 ContextofCare,271

FurtherReading,271

19 ChemotherapyandHormones, 272

AnneL.Thomas

Introduction,272

GeneralIndicationsforChemotherapy,272 DevelopmentandTestingofAnticancerAgents,272 PhaseIStudies,273 PhaseIIStudies,273 PhaseIIIStudies,273 AssessingTumourResponses,273

TheEvaluationofTargetedTherapies,273 PrinciplesofCytotoxicTherapy,273 DrugResistance,274

SelectionandSchedulingofChemotherapyAgents, 274

High-DoseChemotherapy,274 RouteofAdministration,274 SideEffectsofChemotherapy,275 ClassificationofCytotoxicDrugs,275 AlkylatingAgents,275 Antimetabolites,275 MitoticInhibitors,278

TopoisomeraseInhibitors,279 Miscellaneous,279

Hormones,280

TargetedTherapies,281

EpidermalGrowthFactorReceptor,282

SignallingThroughRAS-RAF-ERK(MAPK)and PI3K-AKT,282

VascularEndothelialGrowthFactorSignalling Pathway,282

ProteasomeInhibitors,282

Poly(ADP-Ribose)PolymeraseInhibitors,282

CDK4/6Inhibitors,283 Immunotherapy,283

TherapeuticAntibodies,283

ImmuneCheckpointInhibitors,283 FurtherReading,284

20 SkinandLipCancer, 285

CharlesKellyandPaulSymondsand CliffLawrence

Introduction,285

KeratinocyteSkinTumours,285

Aetiology,285

BasalCellCarcinoma,287

SquamousCellCarcinomaoftheSkin,289

CanceroftheLip,289

Keratoacanthoma,289

TreatmentofNonmelanomaSkinCancer,290

RadiotherapyforKeratinocyteSkinCancers,292

ElectronBeamTreatment,293

ElectronBackscatter,293

SuperficialX-RayTreatment,293

ComparisonofOutcomeforDifferentModalitiesin theTreatmentofBasalCellCarcinomas,296 Melanoma,296 Aetiology,296 SubtypesofMelanoma,296 Diagnosis,297 MelanomaTNMStaging,297 StageandPrognosis,297 ManagementofMelanoma,300 AdjuvantTreatmentforMelanoma,301 ManagementofRecurrentorMetastatic Melanoma,301 SideEffectsofImmunotherapy,302 RoleofRadiotherapyinMalignantMelanoma,302 CutaneousLymphomas,303 MerkelCellTumours,303 SkinSarcoma,303 KaposiSarcoma,305 SkinAppendageTumours,305 FurtherReading,306

21 HeadandNeckCancer GeneralPrinciples, 308 ChristopherD.Scrase Introduction,308 Demographics,308 Aetiology,308 PreventionandEarlyDiagnosis,310 TumourTypes,310 Presentation,310 Investigation,310 Nutrition,311 Dentition,311 IndicationsforRadiotherapy,311 DefinitiveRadiotherapy,311 PostoperativeRadiotherapy,311 PalliativeRadiotherapy,311 RadiotherapyPlanning,312 Immobilisation,312 TargetVolumes,312 DefinitiveRadiotherapy,312 PostoperativeRadiotherapy,313 RadiotherapyTechnique,313 ConformalRadiotherapy,313 IntensityModulatedandImageGuided RadiotherapyinHeadandNeckCancers,313 DoseandFractionation,317 DefinitiveRadiotherapy,317 PostoperativeRadiotherapy,318 ChemotherapyinHeadandNeckCancer,318 ConcurrentChemotherapyandDefinitive Radiotherapy,318 ConcurrentChemotherapyandPostoperative Radiotherapy,318 InductionChemotherapy,318 ChemotherapyinthePalliativeSetting,318 ToxicityofTreatment,319 AcuteToxicity,319

LateToxicity,320

FutureDevelopments,320

Immunotherapy,320 FurtherReading,320

22 Sino-Nasal,Oral,LarynxandPharynxCancers, 322

ChristopherD.ScraseandPaulSymonds

Nasopharynx,323

Anatomy,323

IncidenceofNasopharyngealTumours,323

StagingSystemforNasopharyngealTumours,324

Aetiology,PathologyandLymphaticSpread,324

SignsandSymptoms,324

DiagnosisandStaging,324 Treatment,324

RadiationTechnique,325 Complications,325 Follow-up,325 Results,326

NoseandNasalCavity,326

Anatomy,326

Incidence,328

StagingSystem,328

Aetiology,PathologyandLymphaticSpread,328

SignsandSymptoms,328

DiagnosisandStaging,328

Treatment,328

Complications,330 Results,330

ParanasalSinusTumours,330

Anatomy,330

IncidenceofParanasalSinusTumours,330

StagingSystemforParanasalSinusTumours,330

Aetiology,PathologyandLymphaticSpread,331

SignsandSymptoms,331

DiagnosisandStaging,332

Treatment,332

Complications,332 Follow-up,333 Results,333

LipandOralCavityCarcinoma,333

Anatomy,333

IncidenceofOralCavityCarcinoma,333

StagingSystemforOralCavityandLipCarcinoma (TNM,8thEdition),333

Aetiology,PathologyandLymphaticSpread,334

SignsandSymptoms,334

DiagnosisandStaging,335

TreatmentLipCancers,336

RadiotherapyTechnique,337

RadiotherapyTechnique,338

Follow-up,338

ResultsofTreatment,338

OropharyngealCarcinoma,338

Anatomy,338

StagingSystemofOropharyngealTumours,339

Aetiology,PathologyandLymphaticSpread,339

SignsandSymptoms,339

DiagnosisandStaging,340 Treatment,340

RadiationTechnique,340 Complications,342

Follow-up,342 Results,342

Larynx,342

Anatomy,342

IncidenceofLaryngealCancer,343

StagingSystemforLaryngealCancer(TNM,8th Edition),343

Aetiology,PathologyandLymphaticSpread,344

SignsandSymptoms,344

DiagnosisandStaging,344

Treatment,345

GlotticCancers,345

ComplicationsofTreatmentforEarlyLaryngeal Cancer,345

ResultsofTreatment,348

HypopharyngealCarcinoma,348

Anatomy,348

IncidenceofHypopharyngealTumours,348

StagingSystemofHypopharyngealTumours (TNM,8thEdition),348

Aetiology,PathologyandLymphaticSpread,348

SignsandSymptoms,348 DiagnosisandStaging,348 Treatment,348

RadiotherapyTechnique,348 Complications,351 Follow-up,351 Results,352

FurtherReading,352

23 ThyroidCancer, 353

CharlesKellyandPaulSymonds IntroductionandEpidemiology,353 Anatomy,353

AetiologicalFactors,353

Presentation,DiagnosisandPatientPathway,354 DifferentiatedThyroidCancer,355

ManagementofDifferentiatedThyroid Cancer,356 Surgery,356

RadioiodineAblation,357

Thyroglobulin,358

ManagementofHypocalcaemia,358

ManagementofLocoregionalRecurrence,358 MetastaticDisease,358

MedullaryThyroidCancer,358

AnaplasticThyroidCancer,359

ThyroidLymphoma,359

ThyroidSarcoma,359

HurthleCellCarcinoma,359

ExternalBeamRadiotherapyforThyroid Cancer,359

AsAdjuvantTreatment,359

PalliativeHighDose,360

LowDosePalliation,360

RadiotherapyforThyroidLymphoma,362 Follow-UpPolicyforThyroidCancer Patients,363 FurtherReading,363

24 GastrointestinalCancer, 364

SomnathMukherjeeandMariaHawkins CanceroftheOesophagus,364 Epidemiology,364

AetiologyandPathology,365

RiskFactorsforSquamousCellCarcinomas,365 RiskFactorsforAdenocarcinoma,365 Anatomy,365 ClinicalManifestations,365 DiagnosticEvaluation,365 Therapy,366

RadicalRadiotherapy,366 DefinitiveChemoradiation,366 NeoadjuvantChemoradiation,366

AdjuvantRadiationorChemoradiation,367 PalliativeRadiotherapy,367 RadiationTherapyTechniques,367 Chemotherapy,369 OtherTreatments,369

OesophagogastricJunctionalTumours,369 Summary,369

CanceroftheStomach,369 Anatomy,369 Epidemiology,369 Aetiology,369 Pathology,369 ClinicalFeatures,370 Staging,370 Management,370 RadiationTechniques,371

PalliativeTreatmentsinAdvanced/Metastatic GastricCancer,371 Summary,371

Pancreas,371 Anatomy,371

IncidenceandEpidemiology,372 Pathology,372

DiagnosticEvaluationandImaging,372 Therapy,372

HepatocellularCarcinoma,375 Epidemiology,375 Symptomatology,375 DiagnosticsandClassification,375

GeneralManagementPrinciples,375 SurgicalTherapy,375 LiverTransplantation,375 LocoregionalTreatments,375 SystemicTherapyandMolecularlyTargeted Agents,376

RadiationTherapy,376 PrinciplesofRadiationDelivery,376 FuturePerspectives,377 BiliaryTractCancers,378 PrinciplesofRadiotherapy,378 CanceroftheColonandRectum,378 Epidemiology,378 Aetiology,378 HistopathologyandClinicalFeatures,379 PretreatmentStagingEvaluations,379 StagingSystems,379 ColonCancer TreatmentPrinciples,380 ManagementofAdvancedColorectal Cancer,380 Third-LineOptions,380 RectalCancer TreatmentPrinciples,381 OrgansatRisk,381 AnalCancer,382 EpidemiologyandAetiology,382 Anatomy,382 Histopathology,382 ClinicalFeatures,382 Treatment,383 References(Oesophagogastric),386 References(Pancreas),386 References(hepato-biliary,colo-rectalandanal cancer),386

25 TumoursoftheThorax, 388 MichaelSnee LungCancer,388 Pathology,388 Symptoms,388 DiagnosisandStaging,389 SystemicTreatmentforNonsmallCellLung Cancer,394 Chemotherapy,394 TargetedTherapy,395 ImmuneTherapy,395 SmallCellLungCancer,395 NeuroendocrineTumours,396 Mesothelioma,396 Symptoms,397 Diagnosis,397 PathologyandNaturalHistory,397 Management,397 Conclusion,398 FurtherReading,398

26 BreastCancer, 399 IanKunkler Anatomy,400 LymphaticDrainage,400 Pathology,400 Epidemiology,400 Aetiology,400 DuctalandLobularCarcinomaInSitu,402 InvasiveBreastCancer,402

MolecularClassificationofBreastCancer,402

MultidisciplinaryManagementofBreastCancer,402 Diagnosis,403

ClinicalAssessment,403

BreastUltrasound,403

MagneticResonanceImaging,404

PositronEmissionTomography,404

ObtainingaHistologicalDiagnosis,404 Staging,404

StagingInvestigations,405 ManagementofDuctalCarcinomaInSitu,406

RoleofPostoperativeRadiotherapyforDuctal CarcinomaInSitu,407

PrognosticandPredictiveFactorsforInvasiveBreast Cancer,408 Stage,408

Age,408

TumourSize,408

AxillaryNodeStatus,408

HER2/neuStatus,409

LymphovascularInvasion,409

PrognosticIndices,409

HormonalReceptorStatus,409 Ki67,409

MolecularSubtype,409

GeneProfiling,409

EndocrineTherapy,409

MastectomyorBreastConservation,410 ManagementoftheAxilla,411 RegionalNodalIrradiation,411 IndicationsforInternalMammaryIrradiation,413

PostoperativeRadiotherapy,413 TargetVolumeandTechniquesforLocoregional Irradiation,416

ComputedTomographySimulation,416 IntensityModulatedRadiotherapy,416 ShoulderField,417

NeoadjuvantTherapy,417

AdjuvantHormonalandCytotoxicTherapy,425 Rationale,425

WhoBenefits?,426

AdjuvantEndocrineTherapy,426

AdjuvantTamoxifen,427

AromataseInhibitors,427

AdjuvantHormonalTherapyAfter5Yearsof Tamoxifen,428

ToxicityofTamoxifen,429

TamoxifenPlusChemotherapy,429

AdjuvantOvarianSuppression,429

Adjuvant/NeoadjuvantCombinationChemotherapy (Polychemotherapy),429

NeoadjuvantChemotherapy,429

PostoperativeAdjuvantChemotherapy,430 HER2PositiveBreastCancer,430

TripleNegativeBreastCancer,434

AdjuvantChemotherapyinOlderPatients,434 ManagementofLocallyAdvancedBreastCancer,434

ClinicalFeatures,434 Diagnosis,434 PrinciplesofManagement,434 RoleofSurgery,434 ChoiceofSystemicTherapy,434 HormonalTherapy,435

LocoregionalTherapy,435 TargetVolume,435 Technique,435

DosageandFractionation(Radical),435 LocoregionalPalliativeRadiotherapy,435 Technique,435 Dose,435

BoneMetastases:PreventionandTreatment,435 PalliativeRadiotherapyforBoneMetastases,436 PalliativeSurgery,436 PrinciplesofManagement,436 MedicalManagementofAdvancedandMetastatic Disease,436 MenopausalStatusandHormoneReceptor Status,436 SitesofMetastasesandImpactonManagement,437 CytotoxicTherapy,437

MorbidityofChemotherapy(Adjuvantandfor MetastaticDisease),440 BoneMarrowInvolvement,440 GrowthFactorSupport,441

ClinicalOutcomesinEarlyandAdvancedMetastatic BreastCancer,441 Follow-Up,441

Follow-UpAfterBreast-ConservingTherapy,442 Follow-UpAfterMastectomy,442 BreastCancerinPregnancy,442 BreastCancerinMales,443 FurtherReading,443

27 GynaecologicalCancer, 444

ChristopherKentandPaulSymonds Anatomy,444

IncidenceofGynaecologicalCancer,444 CarcinomaofCervix,444

CausesofCervicalNeoplasia,444 PathologyofCervicalCancer,444 SymptomsandInvestigationsofCervical Cancer,445

Treatment,448

TreatmentofStageII–IVa,449 FutureTrends,451 CarcinomaofEndometrium,452 Pathology,453 RoutesofSpread,453 Treatment,453

PostoperativeRadiotherapy,453 FutureTrends,454

SarcomasoftheUterus,454 CanceroftheOvary,454 Aetiology,454

Another random document with no related content on Scribd:

They resumed their march toward the palace. His ears keenly alert for sounds of pursuit, Robert, too, fancied several times that he heard cautious footsteps following in the distance; but he finally concluded that what he heard was nothing more than the countless rustling echoes from their own footsteps.

At last they reached a winding stairway. Up this they followed Dyarkon till it brought them to another level stretch of paving.

At a command from the emperor the guard stopped and fumbled along the base of the right wall. A door in the masonry swung outward. Through this they all followed quickly, closing the door behind them.

They now stood within another passage exactly like the first, but running at right angles to it. Was it imagination that caused Robert to believe he heard a scurry of footsteps along the passage they had just quit?

“Did you hear?” murmured the princess, clutching Robert’s arm. He nodded. Then he was right. They had just quit the other passage in time!

The little procession moved on again. Another short flight of stairs brought them to a stop before a blank wall at the end of the passage. Here Dyarkon repeated his former performances and the wall opened.

A brilliant stream of sunlight burst upon them. The abrupt contrast with the dim glow of the passage all but blinded them for a few seconds.

An involuntary exclamation burst from Robert’s lips. The Sphere rested within fifty feet of them! They were standing inside the broad wall of the palace courtyard!

Instantly his mind formed a plan of action. They would make a dash for the Sphere. Once safely inside they could rise quickly and observe the actions of the crowds. Then they could lay their plans at leisure.

Rapidly he outlined his plan to the others, who acquiesced at once. If their pursuers had already reached the palace they had not a moment to lose. The courtyard was yet closer.

Hakon was able to stand, though his wounds had left him pitifully weak. Dyarkon and the professor now assisted him while Robert hurried ahead to open the trap-door entrance into the Sphere.

As they emerged from the wall a loud outcry greeted them. Without stopping to ascertain its source they hurried toward the Spherewith all possible speed. Fortunately the trap operated readily, and a few seconds later they were all safely shut within.

The outcry was now explained. Into the courtyard from the palace poured a score of nobles with drawn sabers, shouting for them to stop.

Robert jerked the control over. The Sphere leapt from the ground with such sudden force that all except Robert and the staunch Dyarkon were thrown to the floor. A minute later they were soaring far above the heads of their late pursuers.

“Phew! Close shaves are getting to be our specialty,” exclaimed Robert, recovering his breath for the first time in many minutes. “Now for our observations and conference.”

He checked the Sphere’sascent and turned to the others.

Zola was already busily binding her father’s wound. Professor Palmer had just brought her some water and a supply of bandages from the first-aid chest. Fortunately, though Hakon was weak from loss of blood, his wound was found not to be serious.

Hakon was staring intently groundward from his position by a window. Following his gaze, Robert saw a dense mob round the palace. Even at this height he could hear the Martians’ cries faintly. Evidently the rebel noblemen had succeeded well in working the masses up in revolt.

Sadly Hakon viewed the disorder below. It was now clear that it would not be safe for him to return.

“Let us all go to Earth, my dear father,” said Zola. “There we can be happy together.”

The fugitive ruler pondered for many minutes, while the others maintained a respectful silence. Finally he sighed resignedly. A faint smile played over his countenance as he turned to his daughter.

“Ah, my dear, I was a very foolish old man to think of letting you go alone. We shall, as you say, be far happier together. We shall have riches and contentment in this world of Robert’s—if, indeed, he and Professor Palmer will share a little of their fortune with us.” He smiled as he nodded toward the bullion stacked on the chamber floor.

“You are the spokesman, Robert,” chuckled the professor.

“The treasure is yours and Zola’s, sire, now that you are with us,” said Robert.

“I have given it to you and Professor Palmer, my boy, and it remains yours, except for what small portion you might wish to assign me—and Dyarkon, if he decides to go with us. As for Zola, she will share with you as your bride. What say you, Dyarkon—do you wish to go with us?”

“Oh, sire, I shall go if you desire it; but I was to have been married shortly. My heart is there.” He pointed below.

“Then you shall be permitted to return, my man. Accept this, my present to your bride; and may you have great happiness.” He handed the guard a string of beautiful emeralds which he had been wearing.

The faithful Martian was speechless with gratitude.

“I suggest, then, that the treasure be divided into four equal parts,” said the professor, presently; “one quarter for each of us. There is sufficient wealth here to make every one of us overwhelmingly rich on Earth.”

So it was agreed.

The question of provisions was the next consideration. At Hakon’s orders, large quantities of evaporated fruits and vegetables had previously been placed within the cupboards of the Sphere. A goodly quantity of the Sphere’s original supply of food tablets, etc., remained. Fortunately, too, the oxygen tanks contained enough gas to purify the air in the Spherefor a long while. It only was necessary to replenish their water supply, when they could also leave Dyarkon.

The latter task was not so easy as it sounds. For there are no convenient, open streams on Mars. They must either chance landing

at some power station or farm, or fly to one of the poles and there obtain water from one of the giant reservoirs. The elements at the nearest pole being very treacherous at this season, it was decided to chance a visit to some farmhouse.

A hurried trip was accordingly made to a small farm, a sufficient distance from the scene of the rebellion to be reasonably safe. Here the astonished farmer, who had not yet heard of the rebellion and who did not even recognize the emperor and the princess, eagerly helped these distinguished visitors to fill the water tanks of the mysterious Sphere. This the farmer had heard of, and both he and his wife gazed upon it with mingled wonder and dismay. Afterward they followed it with their eyes until it had passed beyond their vision. This farmer, and his wife and Dyarkon, had the distinction of being the persons on Mars who last saw their emperor; though the two first named did not know this till Dyarkon presently told them.

After the filling of the water tanks, Robert steered the Sphere straight toward the distant pale star which he and Professor Palmer knew was the Earth. Despite their anticipation and resignation, Zola and her father gazed back upon their erstwhile world in silent awe, and not without some sadness, long after it had ceased to be more than a mere ocher and rose disk.

Through the eternal night sped the infinitesimal world with its population of four. And through the long hours of Robert’s watches, Zola was at his side always. Their love was as an immortal thing, born of space and eternity. Hand in hand they fled across the universe to their future world of promise.

Profiting by their previous experience with gravitation, or rather, an absence of gravitation and stabilization, Robert and the professor properly manipulated the disk and gyrostats on this trip, avoiding the danger which had so nearly proved their undoing before. Robert prevented also the recurrence of another unpleasant experience, by cutting short pieces of stout cord, one for each of them, and particularly cautioned Zola and her father to tie them about their bodies at night and secure the other end to a rung or some other stationary object at a safe distance from the whirling gyrostats.

It was not long after that they had a taste of air-floating, and the cords proved their worth. This sensation, the continued sunshine out of a black sky and other phenomena, were all new to Zola and her father. The time passed rapidly.

A deck of playing cards was got out and Hakon and Zola were initiated into the mysteries of the Earthmen’s card games, which they learned readily and seemed to enjoy keenly. They then proceeded to show Robert and Professor Palmer some of their own games. These, being played with cards not greatly different from our own, were easily adapted to the cards they were using. In fact, one of their games, called Agahr, was virtually identical with our own simple game of casino.

So it did not seem long ere they were within a day’s journey of the Earth. Not a single mishap had delayed their progress so far. Barring the unexpected, they should be but a day longer in returning than the period covered by the trip to Mars, in spite of the considerably increased distance between the two planets by this time. Nearly three months had elapsed since the departure from the Earth.

As the Earth’s disk expanded before their eyes, Robert pointed out to Zola and Hakon the outlines of the continents and oceans, the mountain ranges and rivers. Their genuine wonder and delightful anticipation were a source of keen enjoyment to both the professor and Robert.

“It surpasses my wildest imagination to vision an expanse of water so vast that one can not see its boundaries!” exclaimed Hakon, excitedly. “I can scarcely contain myself till we shall actually see these wonders with our own eyes.”

“And think, Father, of the great forests of trees where one can really get lost; the mysterious clouds in the sky; the rushing rivers and waterfalls! Oh, how could I have thought of letting you stay away from all this! How happy we can be, can’t we, Robert?”

“Indeed we can, sweetheart,” he replied, with a feeling that his measure of delight was far more than he deserved.

Closer, closer drew the big world—his world and hers. Its great disk swelled and swelled, until it was no longer a disk but a vast expanse stretching away in all directions.

Robert had reduced the Sphere’s speed until they approached the surface, now less than fifty miles away, at about the speed of a fast passenger train. As they drew closer he reduced their speed still further. A big cloud bank obscured their view of the Earth’s surface now, but he knew that they were above the Atlantic. He had already given the Sphere the spin of the swiftly revolving Earth, before entering its envelope of atmosphere. They now drifted serenely, high above the clouds.

As they slowly drew near the cloud bank, Zola made a natural mistake of thinking it the ocean, till Robert told her different. Her astonishment and delight were great as they plunged through the fluffy mist and emerged above the water. A big sea was running, and

Robert permitted the Sphere to drop within a hundred yards of the tall crests.

The continual rolling of the water mystified Hakon and Zola. This was explained to them with some difficulty. Robert opened two of the Sphere’s ports, for the first time since leaving Mars. They all filled their lungs gratefully with the keen, salty air as it blew in upon them. The main force of the gale was not felt, however, because the Sphere was being driven before it. Once an eccentric gust sucked the Sphere down abruptly. A mountainous wave, rearing hungrily toward the big metal ball, slapped forcibly against it, causing it to rebound high into the air with a suddenness that upset everyone. After that Robert kept a safe distance above the seething waters.

For a while they scudded swiftly along under the hypnotic spell of the restless sea. Its hissing turbulence was a source of continual awe and wonder to their guests. Finally Robert closed the ports and sped the Spheretoward the Jersey coast.

It was in the early afternoon when they passed over the coast line. Here their appearance was first noted and news of the Sphere’ssafe return flashed all over the world. Later, as they sailed over New York, a droning of many whistles heralded their arrival, while a blimp, a big seaplane, and several airplanes glided and cavorted over, under and round them.

“Sphere ahoy!” shouted one venturesome chap, a reporter on the Times, as he whizzed by, a dozen feet away, in a two-passenger airplane. “What news?”

But the drone of his engine drowned a possible answer as the distance between them widened rapidly.

Leaving Manhattan, Robert steered the Sphere toward L—- and Professor Palmer’s estate. This was at the latter’s request, and in response to his cordial invitation to Robert and both their guests to make their home with him for the present.

Their arrival at the Palmer estate found the place already overrun with reporters and photographers in anticipation of their return there. Even the resourceful Henry could not stem the tide. Motion

pictures of them all were run off and rushed to headquarters for early projection upon the silver screen all over the world.

Hakon, and Zola, more charming than ever, both accepted the situation with jolly good nature. Praises of the beautiful maiden from Mars were many, and their sincerity was reflected in the headlines and articles which appeared as by magic in the afternoon papers throughout the country the very day of their arrival.

The party rested at the Palmer estate for several days. Many were the delightful strolls which Robert and Zola took in the lovely grounds. The soft, luxuriant grass under foot, the tall trees, the beautiful shrubbery and flowers were as a fairyland to the princess, with her fairy prince at her side. As for Robert, he was in a veritable seventh heaven.

The emperor and Professor Palmer, now great cronies, were constantly together. Halton never tired of the professor’s tales of the Earth’s resources, its history and people; and of our long observation of and conjectures regarding his own planet, Mars.

Negotiations were opened with a firm of expert diamond cutters in New York for the cutting and polishing of the stones brought from Mars. Their representatives, escorted by a heavy guard, arrived promptly and departed with the first valuable consignment of the rough gems.

The balance of the treasure, in bullion and stones, had been safely deposited in the vaults of three different banks for greater safety. The bullion, however, was rapidly converted into cash and deposited in equal shares to the individual credit of the four adventurers and one other person. This person was Taggert’s sweetheart, a Miss Sarah Daugherty, who had waited faithfully for the valiant reporter’s return. By mutual consent, a fifth and equal share of the treasure was allotted her. Taggert’s mother, poor woman, had not lived to see the return of the Sphere. She had contracted pneumonia and passed away a month before her son’s death. One of the first things Robert had done upon his return was to seek Mrs. Taggert and Miss Daugherty, after delivering Taggert’s notes to the Morning Chronicle with an additional report on the

events following the lion-hearted reporter’s death. He obtained the publishers’ ready consent to turn over all salaries and bonus due Taggert, to Miss Daugherty.

From the moment of their return, Robert and Professor Palmer were lionized by the world. Eminent scientists from everywhere sought interviews with them. Even the former opponent of the Palmer theories, Professor Margard, came to Professor Palmer with sincere congratulations. They were besieged by learned societies to lecture at gatherings for their enlightenment. Capitalists and promoters begged them to consider offers of enormous sums for their patents on the Sphere’sremarkable gravity-defying principles.

Construction of a huge device for flashing messages to Mars by means of reflection of the sun’s rays was commenced in the Sahara Desert. A code furnished by the emperor was to be used. Though wireless had been considered, the enormous distance was judged to be too great to make that method of communication practicable, even with the most powerful apparatus then conceivable.

“They’ll be betting on each other’s stock markets soon,” laughed Henry, when he heard of the project.

On the day of Robert’s and Zola’s wedding, the emperor presented his daughter with a magnificent, perfect ruby, which he had had set, and hung in a pendant, with the connivance of the professor. The gem was uniquely cut, similarly to what we know as table-cut. He also presented them with a packet of three remarkable stones, in the rough, which he had secretly brought with him. One of these was a black diamond of twenty-one carats; another was a white diamond of slightly larger size.

The third stone was also a white diamond, but of astounding size. It was several times larger than the famous Koh-i-noor; it even exceeded in size the Great Mogul in the rough, as it balanced at a trifle under 1,115 carats! Properly cut and polished, without the unfortunate bungling which both the Koh-i-noor and the Great Mogul had suffered, it should weigh considerably more than these two famous gems together, they weighing 106 and 280 carats respectively after their final cutting.

“It should be named,” said the professor, when shown this enormous stone. “What are you going to call it?”

“Let us call it the Ragnarok, which means ‘the twilight of the gods and the doomsday of the world’—in memory of the waning world from which it came,” suggested Robert, after some thought.

And so it was named.

The little vine-clad church in the village saw the wedding of Robert and Zola on a delightful, soft autumn afternoon a few days later. Her father gave her away, and Professor Palmer was the best man. Futile attempts at fittingly describing the glorious vision presented by the princess were attempted. But perhaps none was more apt than that ventured by the professor’s housekeeper, a kindly soul, who had helped Zola choose her dainty bridal gown and charming trousseau. “A true daughter of the gods,” was the rather surprizing expression of this normally prosaic woman.

More surprizing, however, may have been the choice of these two young beings of the scene of their honeymoon. Not a tour of Europe, nor of the natural wonders of our own great country. They simply disappeared into the great Canadian wilderness. There, if one could have followed them, they might have been discovered happily paddling a well-loaded canoe up a winding stream of still, friendly, wooded shores. Above, the clear blue sky rivaled the crystal transparency of the rippling stream. A hawk drifted across the ribbon of blue and was lost again beyond the maze of tall pines. Somewhere a woodpecker drummed stoutly upon a dead limb.

Softly, easily, the slim craft rounded a bend to the even thrust of two pairs of vigorous, willing young arms. Like the hawk, it was soon lost to view—lost in a twilight wilderness of love and peace.

[THE END]

Transcriber’s Note: This story appeared in four consecutive issues of WeirdTales magazine starting in November 1925.

*** END OF THE PROJECT GUTENBERG EBOOK THE WANING OF A WORLD

***

Updated editions will replace the previous one—the old editions will be renamed.

Creating the works from print editions not protected by U.S. copyright law means that no one owns a United States copyright in these works, so the Foundation (and you!) can copy and distribute it in the United States without permission and without paying copyright royalties. Special rules, set forth in the General Terms of Use part of this license, apply to copying and distributing Project Gutenberg™ electronic works to protect the PROJECT GUTENBERG™ concept and trademark. Project Gutenberg is a registered trademark, and may not be used if you charge for an eBook, except by following the terms of the trademark license, including paying royalties for use of the Project Gutenberg trademark. If you do not charge anything for copies of this eBook, complying with the trademark license is very easy. You may use this eBook for nearly any purpose such as creation of derivative works, reports, performances and research. Project Gutenberg eBooks may be modified and printed and given away—you may do practically ANYTHING in the United States with eBooks not protected by U.S. copyright law. Redistribution is subject to the trademark license, especially commercial redistribution.

START: FULL LICENSE

THE FULL PROJECT GUTENBERG LICENSE

PLEASE READ THIS BEFORE YOU DISTRIBUTE OR USE THIS WORK

To protect the Project Gutenberg™ mission of promoting the free distribution of electronic works, by using or distributing this work (or any other work associated in any way with the phrase “Project Gutenberg”), you agree to comply with all the terms of the Full Project Gutenberg™ License available with this file or online at www.gutenberg.org/license.

Section 1. General Terms of Use and Redistributing Project Gutenberg™ electronic works

1.A. By reading or using any part of this Project Gutenberg™ electronic work, you indicate that you have read, understand, agree to and accept all the terms of this license and intellectual property (trademark/copyright) agreement. If you do not agree to abide by all the terms of this agreement, you must cease using and return or destroy all copies of Project Gutenberg™ electronic works in your possession. If you paid a fee for obtaining a copy of or access to a Project Gutenberg™ electronic work and you do not agree to be bound by the terms of this agreement, you may obtain a refund from the person or entity to whom you paid the fee as set forth in paragraph 1.E.8.

1.B. “Project Gutenberg” is a registered trademark. It may only be used on or associated in any way with an electronic work by people who agree to be bound by the terms of this agreement. There are a few things that you can do with most Project Gutenberg™ electronic works even without complying with the full terms of this agreement. See paragraph 1.C below. There are a lot of things you can do with Project Gutenberg™ electronic works if you follow the terms of this agreement and help preserve free future access to Project Gutenberg™ electronic works. See paragraph 1.E below.

1.C. The Project Gutenberg Literary Archive Foundation (“the Foundation” or PGLAF), owns a compilation copyright in the collection of Project Gutenberg™ electronic works. Nearly all the individual works in the collection are in the public domain in the United States. If an individual work is unprotected by copyright law in the United States and you are located in the United States, we do not claim a right to prevent you from copying, distributing, performing, displaying or creating derivative works based on the work as long as all references to Project Gutenberg are removed. Of course, we hope that you will support the Project Gutenberg™ mission of promoting free access to electronic works by freely sharing Project Gutenberg™ works in compliance with the terms of this agreement for keeping the Project Gutenberg™ name associated with the work. You can easily comply with the terms of this agreement by keeping this work in the same format with its attached full Project Gutenberg™ License when you share it without charge with others.

1.D. The copyright laws of the place where you are located also govern what you can do with this work. Copyright laws in most countries are in a constant state of change. If you are outside the United States, check the laws of your country in addition to the terms of this agreement before downloading, copying, displaying, performing, distributing or creating derivative works based on this work or any other Project Gutenberg™ work. The Foundation makes no representations concerning the copyright status of any work in any country other than the United States.

1.E. Unless you have removed all references to Project Gutenberg:

1.E.1. The following sentence, with active links to, or other immediate access to, the full Project Gutenberg™ License must appear prominently whenever any copy of a Project Gutenberg™ work (any work on which the phrase “Project Gutenberg” appears, or with which the phrase “Project Gutenberg” is associated) is accessed, displayed, performed, viewed, copied or distributed:

This eBook is for the use of anyone anywhere in the United States and most other parts of the world at no cost and with almost no restrictions whatsoever. You may copy it, give it away or re-use it under the terms of the Project Gutenberg License included with this eBook or online at www.gutenberg.org. If you are not located in the United States, you will have to check the laws of the country where you are located before using this eBook.

1.E.2. If an individual Project Gutenberg™ electronic work is derived from texts not protected by U.S. copyright law (does not contain a notice indicating that it is posted with permission of the copyright holder), the work can be copied and distributed to anyone in the United States without paying any fees or charges. If you are redistributing or providing access to a work with the phrase “Project Gutenberg” associated with or appearing on the work, you must comply either with the requirements of paragraphs 1.E.1 through 1.E.7 or obtain permission for the use of the work and the Project Gutenberg™ trademark as set forth in paragraphs 1.E.8 or 1.E.9.

1.E.3. If an individual Project Gutenberg™ electronic work is posted with the permission of the copyright holder, your use and distribution must comply with both paragraphs 1.E.1 through 1.E.7 and any additional terms imposed by the copyright holder. Additional terms will be linked to the Project Gutenberg™ License for all works posted with the permission of the copyright holder found at the beginning of this work.

1.E.4. Do not unlink or detach or remove the full Project Gutenberg™ License terms from this work, or any files containing a part of this work or any other work associated with Project Gutenberg™.

1.E.5. Do not copy, display, perform, distribute or redistribute this electronic work, or any part of this electronic work, without prominently displaying the sentence set forth in paragraph 1.E.1

with active links or immediate access to the full terms of the Project Gutenberg™ License.

1.E.6. You may convert to and distribute this work in any binary, compressed, marked up, nonproprietary or proprietary form, including any word processing or hypertext form. However, if you provide access to or distribute copies of a Project Gutenberg™ work in a format other than “Plain Vanilla ASCII” or other format used in the official version posted on the official Project Gutenberg™ website (www.gutenberg.org), you must, at no additional cost, fee or expense to the user, provide a copy, a means of exporting a copy, or a means of obtaining a copy upon request, of the work in its original “Plain Vanilla ASCII” or other form. Any alternate format must include the full Project Gutenberg™ License as specified in paragraph 1.E.1.

1.E.7. Do not charge a fee for access to, viewing, displaying, performing, copying or distributing any Project Gutenberg™ works unless you comply with paragraph 1.E.8 or 1.E.9.

1.E.8. You may charge a reasonable fee for copies of or providing access to or distributing Project Gutenberg™ electronic works provided that:

• You pay a royalty fee of 20% of the gross profits you derive from the use of Project Gutenberg™ works calculated using the method you already use to calculate your applicable taxes. The fee is owed to the owner of the Project Gutenberg™ trademark, but he has agreed to donate royalties under this paragraph to the Project Gutenberg Literary Archive Foundation. Royalty payments must be paid within 60 days following each date on which you prepare (or are legally required to prepare) your periodic tax returns. Royalty payments should be clearly marked as such and sent to the Project Gutenberg Literary Archive Foundation at the address specified in Section 4, “Information

about donations to the Project Gutenberg Literary Archive Foundation.”

• You provide a full refund of any money paid by a user who notifies you in writing (or by e-mail) within 30 days of receipt that s/he does not agree to the terms of the full Project Gutenberg™ License. You must require such a user to return or destroy all copies of the works possessed in a physical medium and discontinue all use of and all access to other copies of Project Gutenberg™ works.

• You provide, in accordance with paragraph 1.F.3, a full refund of any money paid for a work or a replacement copy, if a defect in the electronic work is discovered and reported to you within 90 days of receipt of the work.

• You comply with all other terms of this agreement for free distribution of Project Gutenberg™ works.

1.E.9. If you wish to charge a fee or distribute a Project Gutenberg™ electronic work or group of works on different terms than are set forth in this agreement, you must obtain permission in writing from the Project Gutenberg Literary Archive Foundation, the manager of the Project Gutenberg™ trademark. Contact the Foundation as set forth in Section 3 below.

1.F.

1.F.1. Project Gutenberg volunteers and employees expend considerable effort to identify, do copyright research on, transcribe and proofread works not protected by U.S. copyright law in creating the Project Gutenberg™ collection. Despite these efforts, Project Gutenberg™ electronic works, and the medium on which they may be stored, may contain “Defects,” such as, but not limited to, incomplete, inaccurate or corrupt data, transcription errors, a copyright or other intellectual property infringement, a defective or

damaged disk or other medium, a computer virus, or computer codes that damage or cannot be read by your equipment.

1.F.2. LIMITED WARRANTY, DISCLAIMER OF DAMAGES - Except for the “Right of Replacement or Refund” described in paragraph 1.F.3, the Project Gutenberg Literary Archive Foundation, the owner of the Project Gutenberg™ trademark, and any other party distributing a Project Gutenberg™ electronic work under this agreement, disclaim all liability to you for damages, costs and expenses, including legal fees. YOU AGREE THAT YOU HAVE NO REMEDIES FOR NEGLIGENCE, STRICT LIABILITY, BREACH OF WARRANTY OR BREACH OF CONTRACT EXCEPT THOSE PROVIDED IN PARAGRAPH

1.F.3. YOU AGREE THAT THE FOUNDATION, THE TRADEMARK OWNER, AND ANY DISTRIBUTOR UNDER THIS AGREEMENT WILL NOT BE LIABLE TO YOU FOR ACTUAL, DIRECT, INDIRECT, CONSEQUENTIAL, PUNITIVE OR INCIDENTAL DAMAGES EVEN IF YOU GIVE NOTICE OF THE POSSIBILITY OF SUCH DAMAGE.

1.F.3. LIMITED RIGHT OF REPLACEMENT OR REFUND - If you discover a defect in this electronic work within 90 days of receiving it, you can receive a refund of the money (if any) you paid for it by sending a written explanation to the person you received the work from. If you received the work on a physical medium, you must return the medium with your written explanation. The person or entity that provided you with the defective work may elect to provide a replacement copy in lieu of a refund. If you received the work electronically, the person or entity providing it to you may choose to give you a second opportunity to receive the work electronically in lieu of a refund. If the second copy is also defective, you may demand a refund in writing without further opportunities to fix the problem.

1.F.4. Except for the limited right of replacement or refund set forth in paragraph 1.F.3, this work is provided to you ‘AS-IS’, WITH NO OTHER WARRANTIES OF ANY KIND, EXPRESS OR IMPLIED,

INCLUDING BUT NOT LIMITED TO WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PURPOSE.

1.F.5. Some states do not allow disclaimers of certain implied warranties or the exclusion or limitation of certain types of damages. If any disclaimer or limitation set forth in this agreement violates the law of the state applicable to this agreement, the agreement shall be interpreted to make the maximum disclaimer or limitation permitted by the applicable state law. The invalidity or unenforceability of any provision of this agreement shall not void the remaining provisions.

1.F.6. INDEMNITY - You agree to indemnify and hold the Foundation, the trademark owner, any agent or employee of the Foundation, anyone providing copies of Project Gutenberg™ electronic works in accordance with this agreement, and any volunteers associated with the production, promotion and distribution of Project Gutenberg™ electronic works, harmless from all liability, costs and expenses, including legal fees, that arise directly or indirectly from any of the following which you do or cause to occur: (a) distribution of this or any Project Gutenberg™ work, (b) alteration, modification, or additions or deletions to any Project Gutenberg™ work, and (c) any Defect you cause.

Section 2. Information about the Mission of Project Gutenberg™

Project Gutenberg™ is synonymous with the free distribution of electronic works in formats readable by the widest variety of computers including obsolete, old, middle-aged and new computers. It exists because of the efforts of hundreds of volunteers and donations from people in all walks of life.

Volunteers and financial support to provide volunteers with the assistance they need are critical to reaching Project Gutenberg™’s goals and ensuring that the Project Gutenberg™ collection will

remain freely available for generations to come. In 2001, the Project Gutenberg Literary Archive Foundation was created to provide a secure and permanent future for Project Gutenberg™ and future generations. To learn more about the Project Gutenberg Literary Archive Foundation and how your efforts and donations can help, see Sections 3 and 4 and the Foundation information page at www.gutenberg.org.

Section 3. Information about the Project Gutenberg Literary Archive Foundation

The Project Gutenberg Literary Archive Foundation is a non-profit 501(c)(3) educational corporation organized under the laws of the state of Mississippi and granted tax exempt status by the Internal Revenue Service. The Foundation’s EIN or federal tax identification number is 64-6221541. Contributions to the Project Gutenberg Literary Archive Foundation are tax deductible to the full extent permitted by U.S. federal laws and your state’s laws.

The Foundation’s business office is located at 809 North 1500 West, Salt Lake City, UT 84116, (801) 596-1887. Email contact links and up to date contact information can be found at the Foundation’s website and official page at www.gutenberg.org/contact

Section 4. Information about Donations to the Project Gutenberg Literary Archive Foundation

Project Gutenberg™ depends upon and cannot survive without widespread public support and donations to carry out its mission of increasing the number of public domain and licensed works that can be freely distributed in machine-readable form accessible by the widest array of equipment including outdated equipment. Many

small donations ($1 to $5,000) are particularly important to maintaining tax exempt status with the IRS.

The Foundation is committed to complying with the laws regulating charities and charitable donations in all 50 states of the United States. Compliance requirements are not uniform and it takes a considerable effort, much paperwork and many fees to meet and keep up with these requirements. We do not solicit donations in locations where we have not received written confirmation of compliance. To SEND DONATIONS or determine the status of compliance for any particular state visit www.gutenberg.org/donate.

While we cannot and do not solicit contributions from states where we have not met the solicitation requirements, we know of no prohibition against accepting unsolicited donations from donors in such states who approach us with offers to donate.

International donations are gratefully accepted, but we cannot make any statements concerning tax treatment of donations received from outside the United States. U.S. laws alone swamp our small staff.

Please check the Project Gutenberg web pages for current donation methods and addresses. Donations are accepted in a number of other ways including checks, online payments and credit card donations. To donate, please visit: www.gutenberg.org/donate.

Section 5. General Information About Project Gutenberg™ electronic works

Professor Michael S. Hart was the originator of the Project Gutenberg™ concept of a library of electronic works that could be freely shared with anyone. For forty years, he produced and distributed Project Gutenberg™ eBooks with only a loose network of volunteer support.

Project Gutenberg™ eBooks are often created from several printed editions, all of which are confirmed as not protected by copyright in the U.S. unless a copyright notice is included. Thus, we do not necessarily keep eBooks in compliance with any particular paper edition.

Most people start at our website which has the main PG search facility: www.gutenberg.org.

This website includes information about Project Gutenberg™, including how to make donations to the Project Gutenberg Literary Archive Foundation, how to help produce our new eBooks, and how to subscribe to our email newsletter to hear about new eBooks.

Turn static files into dynamic content formats.

Create a flipbook
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.